175 related articles for article (PubMed ID: 30225581)
1. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in endometrial cancer.
Gharaee N; Pourali L; Jafarian AH; Hashemy SI
Mol Biol Rep; 2018 Dec; 45(6):2257-2262. PubMed ID: 30225581
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in colorectal cancer.
Lorestani S; Ghahremanloo A; Jangjoo A; Abedi M; Hashemy SI
Mol Biol Rep; 2020 May; 47(5):3469-3474. PubMed ID: 32277443
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata.
González-Santana A; Marrero-Hernández S; Dorta I; Hernández M; Pinto FM; Báez D; Bello AR; Candenas L; Almeida TA
Fertil Steril; 2016 Nov; 106(6):1521-1529. PubMed ID: 27456549
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer.
Davoodian M; Boroumand N; Mehrabi Bahar M; Jafarian AH; Asadi M; Hashemy SI
Mol Biol Rep; 2019 Feb; 46(1):1285-1293. PubMed ID: 30684188
[TBL] [Abstract][Full Text] [Related]
5. The effect of CP96,345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis.
Lau HY; Bhatia M
J Pathol; 2006 Feb; 208(3):364-71. PubMed ID: 16369913
[TBL] [Abstract][Full Text] [Related]
6. Induction of the neurokinin 1 receptor by TNFα in endometriotic tissue provides the potential for neurogenic control over endometriotic lesion growth.
McKinnon BD; Evers J; Bersinger NA; Mueller MD
J Clin Endocrinol Metab; 2013 Jun; 98(6):2469-77. PubMed ID: 23553861
[TBL] [Abstract][Full Text] [Related]
7. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
8. Normative distribution of substance P and its tachykinin neurokinin-1 receptor in the medullary serotonergic network of the human infant during postnatal development.
Bright FM; Byard RW; Vink R; Paterson DS
Brain Res Bull; 2018 Mar; 137():319-328. PubMed ID: 29331576
[TBL] [Abstract][Full Text] [Related]
9. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.
Al-Keilani MS; Bdeir R; Elstaty RI; Alqudah MA
BMC Cancer; 2023 Feb; 23(1):158. PubMed ID: 36797689
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of Substance P and NK-1 Receptor in ADIPOSE Stem Cells.
Muñoz M; Muñoz MF; Ayala A
J Cell Biochem; 2017 Dec; 118(12):4686-4696. PubMed ID: 28500728
[TBL] [Abstract][Full Text] [Related]
11. Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.
Palma C; Nardelli F; Manzini S; Maggi CA
Br J Cancer; 1999 Jan; 79(2):236-43. PubMed ID: 9888463
[TBL] [Abstract][Full Text] [Related]
12. Substance P and the neurokinin-1 receptor expression in dog ileum with and without inflammation.
Polidoro G; Giancola F; Fracassi F; Pietra M; Bettini G; Asti M; Chiocchetti R
Res Vet Sci; 2017 Oct; 114():297-307. PubMed ID: 28628846
[TBL] [Abstract][Full Text] [Related]
13. High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis.
Chen XY; Ru GQ; Ma YY; Xie J; Chen WY; Wang HJ; Wang SB; Li L; Jin KT; He XL; Mou XZ
Onco Targets Ther; 2016; 9():3595-602. PubMed ID: 27366097
[TBL] [Abstract][Full Text] [Related]
14. [Increased expressions of substance P and neurokinin/tachykinin receptor 1 in eosinophils of patients with psoriasis].
Zuo Z; Wang J; Zhang H; Zheng W; Zhang Z; He S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):966-970. PubMed ID: 28712406
[TBL] [Abstract][Full Text] [Related]
15. Bladder inflammatory transcriptome in response to tachykinins: neurokinin 1 receptor-dependent genes and transcription regulatory elements.
Saban R; Simpson C; Vadigepalli R; Memet S; Dozmorov I; Saban MR
BMC Urol; 2007 May; 7():7. PubMed ID: 17519035
[TBL] [Abstract][Full Text] [Related]
16. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
17. Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi
Suthiram J; Pieters A; Mohamed Moosa Z; Zeevaart JR; Sathekge MM; Ebenhan T; Anderson RC; Newton CL
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768456
[TBL] [Abstract][Full Text] [Related]
18. Role of neurogenic substance P in overexpression of alveolar macrophages' neurokinin 1 receptor in mice exposed to cigarette smoke.
Xu J; Xu F
Exp Lung Res; 2010 May; 36(4):243-54. PubMed ID: 20426532
[TBL] [Abstract][Full Text] [Related]
19. Up-regulated expression of substance P in CD8
Zhang Z; Zheng W; Xie H; Chai R; Wang J; Zhang H; He S
J Transl Med; 2017 May; 15(1):93. PubMed ID: 28460633
[TBL] [Abstract][Full Text] [Related]
20. Expression of the neurokinin type 1 receptor in the human colon.
Boutaghou-Cherid H; Porcher C; Liberge M; Jule Y; Bunnett NW; Christen MO
Auton Neurosci; 2006 Jan; 124(1-2):9-17. PubMed ID: 16305827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
